XGN Stock Analysis: Buy, Sell, or Hold?
XGN - Exagen Inc. Common Stock
$3.64
-0.21 (-5.45%)
▼
5d:
+23.39%
30d:
+19.34%
90d:
+10.98%
HOLD
MODERATE Confidence
Analysis Updated: May 15, 2026 12:00 AM ET
Earnings: May 11, 2026
0d
Get Alerted When XGN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
1 traders called XGN this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD - EXTENDED: XGN is 11.3% above its trading range ($3.27). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
📊 HOLD - EXTENDED: XGN is 11.3% above its trading range ($3.27). Fundamentals are solid but entry is stretched. Hold existing positions; wait for pullback to add new shares.
In-depth Analysis How we analyze
Valuation Analysis: XGN is currently trading at $3.64, which is considered extended relative to its 30-day fair value range of $2.76 to $3.27.
Technical Outlook: Technically, XGN is in a strong downtrend. Immediate support is located at $2.82, while resistance sits at $4.13. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: XGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.67 (+138.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, XGN is in a strong downtrend. Immediate support is located at $2.82, while resistance sits at $4.13. Short-term momentum is weak, with the stock down 5.5% recently.
Market Sentiment: XGN has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $8.67 (+138.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$2.76 -
$3.27
Company Quality Score
61/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
47.4%
All Signals
- BEARISH: Price significantly overextended (+11.3% above its trading range)
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-5.5%)
- BULLISH: Trading 138.1% below Wall St target ($8.67)
Trading Range Analysis
30-Day Trading Range
$2.76 -
$3.27
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$2.82
Resistance Level
$4.13
Current Trend
Strong Downtrend
Technical data as of
May 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-8.47
Wall Street Target
$8.67
(+138.1%)
Revenue Growth (YoY)
11.7%
Profit Margin
-29.5%
Share & Embed Analysis
Last updated: May 18, 2026 5:10 AM ET
Data refreshes hourly during market hours. Next update: 6:10 AM
Data refreshes hourly during market hours. Next update: 6:10 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is XGN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
2
Sells
Net
INSIDERS SELLING
Recent Transactions
John Aballi
SELL
15698 shares
2026-03-03
John Aballi
SELL
11430 shares
2026-02-24
Top Rated Diagnostics & Research Stocks
Top-rated stocks in Diagnostics & Research by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
TMO
Thermo Fisher Scientific… |
STRONG BUY
31 analysts |
$613 | 54 HOLD |
|
EXAS
EXACT Sciences Corporati… |
STRONG BUY
26 analysts |
$106 | 65 BUY |
|
DHR
Danaher Corporation |
STRONG BUY
26 analysts |
$248 | 53 HOLD |
|
GH
Guardant Health Inc |
STRONG BUY
24 analysts |
$131 | 60 HOLD |
|
NTRA
Natera Inc |
STRONG BUY
21 analysts |
$261 | 49 HOLD |
